NPI registry status
Active
2026 NPPES data Endocrinology, Diabetes & Metabolism Physician NPI 1568884559 M.D.
Verify on CMS → Iqra Javeed, M.D.
Endocrinology, Diabetes & Metabolism Physician in Burlington, Massachusetts.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 7,871 in Endocrinology, Diabetes & Metabolism Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
2K
Medicare Part D claims · 490 beneficiaries · Endocrinology, Diabetes & Metabolism Physician avg: 3K
Generic prescribing
46%
generic claims · 46% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
91.4/100
▲ 8 pts above national avg 83.5 · Exceptional
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Iqra Javeed, M.D. reported a CMS MIPS final score of 91.4/100 - above the 83.5 national average - and filed 2,240 Medicare Part D claims in 2023.
- 91.4/100
- MIPS score · +8 vs avg
- 2K
- Part D claims, 2023
- 46%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
CMS NPPES provider registry desk
NPI 1568884559 · Endocrinology, Diabetes & Metabolism Physician
NPI-10 · ENUM-MID · TAX-MID · MIPS-ABOVE · RX-MID · BOOK-THIN · PHOTO-FINISH
- NPI-10 1568884559
- ENUM-MID 2014
- TAX-MID 8K Endocrinology, Diabetes
- MIPS-ABOVE 91.4/100
- RX-MID 2,240
- BOOK-THIN 359 in Massachusetts
- PHOTO-FINISH Allison Estrada · ±0.0
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Javeed · this pr…
Javeed · this provider
91.4 MIPS pts
- Ayesha Mehfooz ·…
Ayesha Mehfooz
91.4 MIPS pts
- Allison Estrada …
Allison Estrada
91.4 MIPS pts
- Lisa Fish · near
Lisa Fish
91.4 MIPS pts
- Laura Lafave · n…
Laura Lafave
91.4 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Iqra Javeed, M.D.'s MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
91 ≥ 61st percentile 61% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Iqra Javeed, M.D. sits
This provider among endocrinology, diabetes & metabolism physician peers
Across the 2,341 endocrinology, diabetes & metabolism physician providers who report both Medicare Part D prescribing and a MIPS quality score, Iqra Javeed, M.D. writes more Part D claims than 48% of them and scores higher on MIPS quality than 65% - placing this provider in the lower-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one endocrinology, diabetes & metabolism physician peer from a representative sample of 60; the gold marker is Iqra Javeed, M.D.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Iqra Javeed, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Iqra Javeed, M.D.?
High performer (top quartile)Primary specialty
Endocrinology, Diabetes & Metabolism Physician
Medicare Part D claims
2,240 15% vs specialty avg
MIPS final score
91.4/100 7.9 pts vs avg
Specialty distribution in Massachusetts
How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among Massachusetts providers
Medicare quality performance, MIPS
Iqra Javeed, M.D.'s 2023 MIPS final score plotted against the Endocrinology, Diabetes & Metabolism Physician national average
- MIPS Final Score
- 91.4/100
- vs 83.5 national avg · 2023 performance year
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1568884559 |
|---|---|
| Specialty | Endocrinology, Diabetes & Metabolism Physician |
| Credentials | M.D. |
| Gender | Female |
| NPI Issued | 01/10/2014 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
91.4157
Final Score
Measured-score avg: 83.5
76.877
Quality
100
Promoting Interoperability
Reporting: Alternative Payment Model
Hospital and facility affiliations
Facilities where Iqra Javeed, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Lahey Clinic Inc
Ipswich, MA
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
License & disciplinary context - Massachusetts BORIM 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~38K Massachusetts medical licensees in 2023 - they are NOT specific to Iqra Javeed, M.D.. To verify Iqra Javeed, M.D.'s current license status, search the BORIM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
80
Total board actions, Massachusetts 2023
Across 78 cases
2.11
Actions per 1,000 licensees
Massachusetts statewide rate
probation
Most common action type
29 cases
BORIM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Massachusetts disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Above average
Iqra Javeed, M.D. - brand share 46.0%
Endocrinology, Diabetes & Metabolism Physician average
46% brand-name claims vs 46% generic, on 2,240 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
2,240
Total Claims
$1.3M
Total Drug Cost
490
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 5,179
- Total Day Supply
- 153,579
- Brand vs Generic
- 46% brand / 46% generic
- Brand Drug Cost
- $1.2M
- Generic Drug Cost
- $26K
Patient Demographics
- Average Patient Age
- 72.8 years
- Avg HCC Risk Score
- 1.57
- Gender Split
- 59% female / 41% male
- Age Distribution
- <65: 54, 65-74: 226, 75-84: 166, 85+: 44
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Iqra Javeed, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Levothyroxine Sodium
Levothyroxine Sodium
290 claims
- Trulicity
Trulicity
208 claims
- Metformin Hcl
Metformin Hcl
147 claims
- Jardiance
Jardiance
122 claims
- Alendronate Sodium
Alendronate Sodium
119 claims
- Ozempic 112
Ozempic
112 claims
- Metformin Hcl Er 80
Metformin Hcl Er
80 claims
- Atorvastatin Calcium 70
Atorvastatin Calcium
70 claims
| Drug | Claims |
|---|---|
| Levothyroxine Sodium | 290 |
| Trulicity Dulaglutide | 208 |
| Metformin Hcl | 147 |
| Jardiance Empagliflozin | 122 |
| Alendronate Sodium | 119 |
| Ozempic Semaglutide | 112 |
| Metformin Hcl Er Metformin Hcl | 80 |
| Atorvastatin Calcium | 70 |
| Glipizide | 54 |
| Glipizide Er Glipizide | 45 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
More Endocrinology, Diabetes & Metabolism Physician in MA →
All providers in Massachusetts →
Compare specialties →
Endocrinology, Diabetes & Metabolism Physician Overview
How Iqra Javeed, M.D. fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.
7,871
Endocrinology, Diabetes & Metabolism Physician Providers in US
54
States with Endocrinology, Diabetes & Metabolism Physician
2,639
Avg Claims per Provider
Iqra Javeed, M.D.'s 2,240 claims are below the specialty average of 2,639.
Nationwide Endocrinology, Diabetes & Metabolism Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Javeed, both outside Massachusetts so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (91.4 here).
Same NPPES enumeration year (2014)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Endocrinology, Diabetes & Metabolism Physician Providers in Massachusetts
Other clinicians with the same primary specialty enrolled in Massachusetts, drawn from the same CMS NPPES roster as Javeed.
One of 359 Endocrinology, Diabetes & Metabolism Physician providers enrolled in Massachusetts, 5 are shown here.
Dr. Alice Abbott
MD
Leeds, MA
Dr. Adham Abdel Mottalib
MD
Boston, MA
Dr. Martin Abrahamson
M.D.
Boston, MA
Dr. Gail Adler
MD PHD
Boston, MA
Dr. Alexandra Albert
MD PHD
Worcester, MA
Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Iqra Javeed, M.D.'s specialty? ▼
Iqra Javeed, M.D. specializes in Endocrinology, Diabetes & Metabolism Physician and practices in Burlington, Massachusetts. Credentials: M.D..
How much does Iqra Javeed, M.D. prescribe under Medicare Part D? ▼
In 2023, Iqra Javeed, M.D. wrote 2,240 Medicare Part D claims totaling $1.3M in drug costs for 490 beneficiaries.
What is Iqra Javeed, M.D.'s Medicare quality score? ▼
Iqra Javeed, M.D. has a CMS MIPS Final Score of 91.4/100 (Quality: 76.9). The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Iqra Javeed, M.D. located? ▼
Iqra Javeed, M.D. is located at LAHEY HOSPITAL & MEDICAL CENTER, Burlington, MA, 01805. Phone: (781) 744-2088.
What is Iqra Javeed, M.D.'s NPI number? ▼
Iqra Javeed, M.D.'s National Provider Identifier (NPI) is 1568884559, issued on 01/10/2014.
Does Iqra Javeed, M.D. prescribe more brand-name or generic drugs? ▼
Iqra Javeed, M.D.'s prescribing is 46% brand-name and 46% generic drugs by claim count, with $1.2M in brand drug costs.
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US? ▼
There are 7,871 Endocrinology, Diabetes & Metabolism Physician providers across 54 states in the US. The average Endocrinology, Diabetes & Metabolism Physician provider writes 2,639 Medicare Part D claims per year.
What drugs does Iqra Javeed, M.D. prescribe most often? ▼
Based on 2023 Medicare Part D data, Iqra Javeed, M.D.'s most frequently prescribed drugs include Levothyroxine Sodium, Trulicity, Metformin Hcl. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Iqra Javeed, M.D. accept Medicare? ▼
Iqra Javeed, M.D. appears in CMS Medicare data with 2,240 Part D claims and 490 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Iqra Javeed, M.D.'s credentials? ▼
Iqra Javeed, M.D.'s NPI is 1568884559 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.